WD Rutherford’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-220
Closed -$30.1K 83
2024
Q2
$30.1K Sell
220
-2,680
-92% -$367K 0.02% 91
2024
Q1
$386K Buy
2,900
+255
+10% +$33.1K 0.2% 71
2023
Q4
$346K Sell
2,645
-30
-1% -$3.94K 0.2% 64
2023
Q3
$326K Sell
2,675
-2,500
-48% -$333K 0.22% 62
2023
Q2
$727K Hold
5,175
0.47% 50
2023
Q1
$732K Sell
5,175
-35
-0.7% -$5.01K 0.52% 47
2022
Q4
$815K Sell
5,210
-265
-5% -$38.1K 0.64% 46
2022
Q3
$672K Hold
5,475
0.54% 50
2022
Q2
$728K Hold
5,475
0.56% 45
2022
Q1
$749K Sell
5,475
-45
-0.8% -$6.27K 0.43% 53
2021
Q4
$955K Sell
5,520
-35
-0.6% -$5.33K 0.48% 50
2021
Q3
$807K Buy
5,555
+185
+3% +$27.1K 0.44% 51
2021
Q2
$709K Buy
5,370
+60
+1% +$7.86K 0.39% 51
2021
Q1
$681K Buy
5,310
+1,765
+50% +$217K 0.42% 51
2020
Q4
$422K Buy
+3,545
New +$432K 0.27% 54

Other funds holding DGX

WD Rutherford's DGX Position: Q3 2024 in Review

WD Rutherford sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 220 shares — an estimated $30.1K sold.

WD Rutherford first reported a position in DGX in Q4 2020 and held it in 15 quarters. The position peaked at $955K in Q4 2021. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • WD Rutherford reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • WD Rutherford sold 220 Quest Diagnostics shares in Q3 2024, an estimated $30.1K.
  • WD Rutherford first reported a position in Quest Diagnostics in Q4 2020 and held it in 15 quarters.
  • WD Rutherford's Quest Diagnostics position peaked at $955K in Q4 2021.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on WD Rutherford's 13F filing for Q3 2024, filed 25 Oct 2024.